Paragon 28, Inc. (FNA) News
Filter FNA News Items
FNA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
FNA News Highlights
- For FNA, its 30 day story count is now at 2.
- Over the past 18 days, the trend for FNA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest FNA News From Around the Web
Below are the latest news stories about PARAGON 28 INC that investors may wish to consider to help them evaluate FNA as an investment opportunity.
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy SystemENGLEWOOD, Colo., May 23, 2023--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its Gorilla® Supramalleolar Osteotomy (SMO) Plating and PRESERVE™ SMO Allograft System which were developed to provide surgeons versatility in plate selection and surgical approach for supramalleolar osteotomies. The system includes patent pending drilling and cutting guides to facilitate repeatable and controlled anterior dome, medial opening, and closing wedge osteotomies. The system also includes |
Q1 2023 Paragon 28 Inc Earnings CallQ1 2023 Paragon 28 Inc Earnings Call |
Paragon 28, Inc. (FNA) Reports Q1 Loss, Tops Revenue EstimatesParagon 28, Inc. (FNA) delivered earnings and revenue surprises of -10% and 3.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue GuidanceENGLEWOOD, Colo., May 04, 2023--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended March 31, 2023 and reaffirmed its 2023 net revenue guidance. |
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare ConferenceENGLEWOOD, Colo., April 26, 2023--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will participate in a fireside chat at the Bank of America Securities 2023 Healthcare Conference on Wednesday, May 10, 2023, at 5:20 p.m. Eastern Time / 3:20 p.m. Mountain Time. |
Paragon 28 Launches Phantom® Metatarsal Shortening SystemENGLEWOOD, Colo., April 24, 2023--Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of its Phantom® Metatarsal Shortening System which features a first in-kind intramedullary device for fixation of in-line shortening osteotomies of the lesser metatarsals. These osteotomies are preformed to prevent metatarsalgia and floating toe, two of the most frequently addressed foot and ankle pathologies. The system includes a patent pending cut guide allowing for increased precision when perfo |
Paragon 28 To Report First Quarter Financial Results on May 4, 2023ENGLEWOOD, Colo., April 20, 2023--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the first quarter 2023 after market close on Thursday, May 4, 2023. The company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time. |
Intuitive Surgical, Inc. (ISRG) Surpasses Q1 Earnings and Revenue EstimatesIntuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 3.36% and 6.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Paragon 28's (NYSE:FNA) investors will be pleased with their 11% return over the last yearPassive investing in index funds can generate returns that roughly match the overall market. But you can significantly... |
Q4 2022 Paragon 28 Inc Earnings CallQ4 2022 Paragon 28 Inc Earnings Call |